Vaishampayan U - Search Results

1

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial.

Atkins MB, Plimack ER, Puzanov I, Fishman MN, McDermott DF, Cho DC, Vaishampayan U, George S, Tarazi JC, Duggan W, Perini R, Thakur M, Fernandez KC, Choueiri TK. Atkins MB, et al. Among authors: vaishampayan u. Eur J Cancer. 2021 Mar;145:1-10. doi: 10.1016/j.ejca.2020.12.009. Epub 2021 Jan 4. Eur J Cancer. 2021. PMID: 33412465 Free article. Clinical Trial.

2

Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.

Vaishampayan U, Flaherty L, Du W, Hussain M. Vaishampayan U, et al. Cancer. 2001 Aug 1;92(3):519-23. doi: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-#. Cancer. 2001. PMID: 11505395 Clinical Trial.

3

Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.

El-Rayes BF, Zalupski MM, Shields AF, Vaishampayan U, Heilbrun LK, Jain V, Adsay V, Day J, Philip PA. El-Rayes BF, et al. Among authors: vaishampayan u. J Clin Oncol. 2003 Aug 1;21(15):2920-5. doi: 10.1200/JCO.2003.03.022. J Clin Oncol. 2003. PMID: 12885810 Clinical Trial.

4

A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.

Hussain M, Vaishampayan U, Heilbrun LK, Jain V, LoRusso PM, Ivy P, Flaherty L. Hussain M, et al. Among authors: vaishampayan u. Invest New Drugs. 2003 Nov;21(4):465-71. doi: 10.1023/a:1026259503954. Invest New Drugs. 2003. PMID: 14586215 Clinical Trial.

5

Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.

Vaishampayan U, Fontana J, Du W, Hussain M. Vaishampayan U, et al. Am J Clin Oncol. 2004 Dec;27(6):550-4. doi: 10.1097/01.coc.0000135922.12198.e4. Am J Clin Oncol. 2004. PMID: 15577431 Clinical Trial.

6

Phase II trial of fenretinide in advanced renal carcinoma.

Vaishampayan U, Heilbrun LK, Parchment RE, Jain V, Zwiebel J, Boinpally RR, LoRusso P, Hussain M. Vaishampayan U, et al. Invest New Drugs. 2005 Mar;23(2):179-85. doi: 10.1007/s10637-005-5864-7. Invest New Drugs. 2005. PMID: 15744595 Free article. Clinical Trial.

7

A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

El-Rayes BF, Zalupski MM, Shields AF, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Adsay V, Philip PA. El-Rayes BF, et al. Among authors: vaishampayan u. Invest New Drugs. 2005 Dec;23(6):583-90. doi: 10.1007/s10637-005-1028-z. Invest New Drugs. 2005. PMID: 16034525 Free article. Clinical Trial.

8

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.

Vaishampayan UN, Faulkner JR, Small EJ, Redman BG, Keiser WL, Petrylak DP, Crawford ED. Vaishampayan UN, et al. Cancer. 2005 Oct 15;104(8):1627-32. doi: 10.1002/cncr.21370. Cancer. 2005. PMID: 16138364 Free article. Clinical Trial.

9

Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.

Tripathi RT, Heilbrun LK, Jain V, Vaishampayan UN. Tripathi RT, et al. Urology. 2006 Aug;68(2):296-301. doi: 10.1016/j.urology.2006.02.036. Urology. 2006. PMID: 16904440

10

Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.

Vaishampayan UN, Heilbrun LK, Shields AF, Lawhorn-Crews J, Baranowski K, Smith D, Flaherty LE. Vaishampayan UN, et al. Invest New Drugs. 2007 Feb;25(1):69-75. doi: 10.1007/s10637-006-9005-8. Epub 2006 Aug 26. Invest New Drugs. 2007. PMID: 16937078 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page